STAAR Surgical Company
STAA · NASDAQ
12/27/2024 | 12/29/2023 | 12/30/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1,189 | $1,514 | $2,329 | $4,310 |
| - Cash | $144 | $183 | $86 | $200 |
| + Debt | $39 | $36 | $31 | $32 |
| Enterprise Value | $1,084 | $1,367 | $2,274 | $4,143 |
| Revenue | $314 | $322 | $284 | $230 |
| % Growth | -2.6% | 13.4% | 23.4% | – |
| Gross Profit | $240 | $253 | $223 | $179 |
| % Margin | 76.3% | 78.4% | 78.5% | 77.5% |
| EBITDA | -$6 | $33 | $48 | $37 |
| % Margin | -1.8% | 10.3% | 17% | 16% |
| Net Income | -$20 | $21 | $40 | $28 |
| % Margin | -6.4% | 6.6% | 13.9% | 11.9% |
| EPS Diluted | -0.41 | 0.43 | 0.8 | 0.5 |
| % Growth | -195.3% | -46.3% | 60% | – |
| Operating Cash Flow | $16 | $15 | $36 | $44 |
| Capital Expenditures | -$23 | -$18 | -$18 | -$14 |
| Free Cash Flow | -$8 | -$4 | $18 | $30 |